Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SJIA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 0 results

Large-scale testing (Phase 3)Study completedNCT00144612
What this trial is testing

Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Chugai Pharmaceutical 60
Not applicableLooking for participantsNCT07517250
What this trial is testing

A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients

Who this might be right for
Familial Mediterranean FeverStill DiseaseSystemic Juvenile Idiopathic Arthritis+1 more
Novartis Pharmaceuticals 160
Not applicableUnknownNCT01095146
What this trial is testing

New Candidate Criteria for Diagnosis of Macrophage Activation Syndrome

Who this might be right for
Macrophage Activation SyndromeLymphohistiocytosis, Hemophagocytic
Amrita Institute of Medical Sciences & Research Center 50
Large-scale testing (Phase 3)Ended earlyNCT03265132
What this trial is testing

Evaluate Efficacy and Safety of Anakinra in the Treatment of Still's Disease (SJIA and AOSD)

Who this might be right for
Still's Disease, Adult-OnsetStill's Disease, Juvenile-Onset
Swedish Orphan Biovitrum 13
Testing effectiveness (Phase 2)Study completedNCT00426218
What this trial is testing

Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Arthritis, Juvenile Rheumatoid
Novartis 26
Testing effectiveness (Phase 2)Looking for participantsNCT07203001
What this trial is testing

A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease

Who this might be right for
Still´s Disease
Novartis Pharmaceuticals 30
Large-scale testing (Phase 3)WithdrawnNCT01676948
What this trial is testing

An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals